BiotechTube
Home/Immunic/Dr. H. Daniel Perez
DH

Dr. H. Daniel Perez

Board Member

Immunic

Therapeutic Areas

Multiple SclerosisInflammatory Bowel DiseaseAutoimmune Diseases

Immunic Pipeline

DrugIndicationPhase
Vidofludimus calcium (IMU-838)Relapsing-Remitting Multiple Sclerosis (RRMS)Phase 3
IMU-856Celiac Disease / GI Barrier FunctionPhase 1b
IMU-935 / IMU-856Psoriasis / Inflammatory DiseasesPreclinical / Phase 1

Leadership Team at Immunic

DD
Dr. Daniel Vitt
President, CEO, and Chairman of the Management Board
DA
Dr. Andreas Muehler
Chief Medical Officer
DD
Dr. Duane Nash
Chairman of the Supervisory Board
View full Immunic profile